Glucagonoma
What is a Glucagonoma?
A glucagonoma is a rare pancreatic neuroendocrine tumor (NET) that secretes excessive glucagon, leading to a characteristic syndrome of diabetes, weight loss, and a distinctive skin rash called necrolytic migratory erythema (NME).
Key Facts:
- Extremely Rare: ~1 in 20 million per year
- Location: Pancreas (usually tail)
- Size: Often large at diagnosis (>5 cm)
- Malignant in 50-80%: Often metastatic at diagnosis (liver)
- Peak Age: 50-70 years
How Does High Glucagon Cause Symptoms?
- Glucagon: Hormone that raises blood sugar (opposes insulin)
- Effects of Excess Glucagon:
- Hyperglycemia → diabetes mellitus
- Increased protein breakdown → weight loss, muscle wasting
- Hypoaminoacidemia (low amino acids) → skin rash (necrolytic migratory erythema)
- Increased lipolysis
Classic Triad ("The 4 D's"):
- Dermatitis (Necrolytic Migratory Erythema): Characteristic rash
- Diabetes Mellitus: Mild diabetes
- Deep Vein Thrombosis (DVT): Blood clots
- Depression, Weight Loss (Decline)
Symptoms:
1. Necrolytic Migratory Erythema (NME) - PATHOGNOMONIC (67-90%):
- Appearance: Red, blistering rash → crusting, scaling, central healing with hyperpigmentation
- Distribution: Perineum, groin, buttocks, lower abdomen, legs, face (perioralmost characteristic)
- Cyclical: Lesions come and go, migrate
- Painful, Itchy
- Often mistaken for eczema, psoriasis, or fungal infection initially
2. Diabetes Mellitus (80-90%):
- Usually mild (fasting glucose 120-200 mg/dL)
- Easy to control
3. Weight Loss (70-90%):
- Severe, progressive
- Muscle wasting, cachexia
4. Thromboembolic Events (20-50%):
- Deep vein thrombosis (DVT), pulmonary embolism (PE)
- Increased clotting risk from tumor
5. Other Symptoms:
- Diarrhea (15-30%)
- Glossitis, Cheilitis: Inflammation of tongue, lips
- Brittle Nails
- Depression, Psychiatric Symptoms
- Normocytic Normochromic Anemia
Diagnosis:
1. Serum Glucagon:
- Normal: <50-100 pg/mL
- Glucagonoma: Typically >1000 pg/mL (often 1000-10,000)
- Markedly Elevated Glucagon is Diagnostic
- Other Causes of Mild Elevation (100-500 pg/mL): Cirrhosis, chronic kidney disease, critical illness, starvation, glucocorticoids
2. Imaging (Localize Tumor, Assess Metastases):
- CT or MRI Abdomen: Usually large pancreatic mass (>5 cm), liver metastases common
- Gallium-68 DOTATATE PET/CT: Somatostatin receptor imaging
3. Skin Biopsy (NME):
- Necrolysis in upper epidermis (hallmark finding)
4. Labs:
- Fasting Glucose, HbA1c: Assess diabetes
- Hypoaminoacidemia: Low plasma amino acids
- Hypoalbuminemia, Anemia
- Chromogranin A: Tumor marker (usually elevated)
Treatment:
1. Surgery (If Resectable):
- Tumor Resection ± Metastasectomy: Curative if all tumor removed
- Debulking Surgery: Even if metastatic—reduces hormone levels, improves symptoms (especially rash)
- Note: Many patients have metastases (liver) at diagnosis
2. Somatostatin Analogs (SSAs) - FIRST-LINE for Symptom Control:
- Octreotide (Sandostatin LAR®), Lanreotide (Somatuline®)
- Effects:
- Suppress glucagon secretion
- Dramatic improvement in rash (often complete resolution)
- Slow tumor growth
- Dosing: Long-acting monthly injections
3. For Metastatic/Unresectable Disease:
- Peptide Receptor Radionuclide Therapy (PRRT): Lutetium-177 DOTATATE (Lutathera®)
- Everolimus (Afinitor®): mTOR inhibitor; slows tumor progression
- Chemotherapy: Streptozocin-based regimens (relatively resistant to chemo)
- Liver-Directed Therapies: Embolization, RFA, radioembolization for liver mets
4. Supportive/Symptomatic Treatment:
- Nutritional Support:
- High-protein diet
- Amino acid supplementation (may improve rash)
- Zinc supplementation
- Diabetes Management: Usually easy to control with diet, metformin, or low-dose insulin
- Anticoagulation: If DVT/PE develops (or prophylaxis if high risk)
- Skin Care: Gentle cleansers, emollients for rash
Prognosis:
- Slow-Growing Tumors: Even metastatic disease progresses slowly
- 5-Year Survival:
- Localized: 50-70%
- Metastatic: 30-50%
- Many patients live for years with metastatic disease
- Symptom control (especially rash) greatly improves quality of life
Key Points:
- Glucagonoma = rare pancreatic NET secreting excessive glucagon
- Classic triad: Necrolytic migratory erythema (NME rash), diabetes, weight loss
- NME is pathognomonic—red, blistering rash in groin, perineum, face
- Diagnosis: Markedly elevated glucagon (>1000 pg/mL)
- Treatment: Somatostatin analogs (octreotide, lanreotide) dramatically improve rash and symptoms